Prywatna Praktyka Lekarska Prof. dr hab. med. Paweł Hrycaj

Rheumatoid Arthritis

Arthritis

Systemic Lupus Erythematosus

Imvotamab

GLPG3667

Galapagos

IGM Biosciences

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

A study evaluating the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GLPG3667 administered orally once daily for 48 weeks in approximately 180 adult participants with active Systemic Lupus Erythematosus (SLE).

A Study Evaluating the Effects of GLPG3667 Administered As Oral Treatment in Adult Participants with Active Systemic Lupus Erythematosus

Prywatna Praktyka Lekarska Prof. dr hab. med. Pawe_ Hrycaj | Prywatna Praktyka Lekarska Prof. dr hab. med. Pawe_ Hrycaj

Site insights

Work at this site?

Active trials

A Study Evaluating the Effects of GLPG3667 Administered As Oral Treatment in Adult Participants with Active Systemic Lupus Erythematosus (GALACELA)

Trial sponsors